| Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg (NCT01929512) | Hanmi Pharmaceutical Company Limited | 2013-06-01 |
| A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers. (NCT01920854) | Rockwell Medical Technologies, Inc. | 2013-06-01 |
| Effects of Oxygen Status on Hypoxia Inducible Factor 1-α and Inflammation. A Pilot Proof of Principle Study. (NCT01889823) | Radboud University Medical Center | 2013-06-01 |
| EVP-6124 Hepatic Impairment Study (NCT01984736) | FORUM Pharmaceuticals Inc | 2013-06-01 |
| Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations (NCT01777412) | Johns Hopkins University | 2013-06-01 |
| A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants (NCT01866033) | Janssen Research & Development, LLC | 2013-06-01 |
| Exploratory Study of NS-065/NCNP-01 in DMD (NCT02081625) | National Center of Neurology and Psychiatry, Japan | 2013-06-01 |
| Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) | Northwest Biotherapeutics | 2013-06-01 |
| Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (NCT01887834) | The Canadian College of Naturopathic Medicine | 2013-06-01 |
| Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension (NCT01873885) | PhaseBio Pharmaceuticals Inc. | 2013-06-01 |
| Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance (NCT02080715) | University of Zurich | 2013-06-01 |
| Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy (NCT01828346) | TetraLogic Pharmaceuticals | 2013-06-01 |
| Botulinum Toxin Injection to Prevent VT Storm (NCT02003027) | Meshalkin Research Institute of Pathology of Circulation | 2013-06-01 |
| Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma (NCT01874054) | Seagen Inc. | 2013-06-01 |
| Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru (NCT01187108) | University of Colorado, Denver | 2013-06-01 |
| Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 (NCT01886976) | Chinese PLA General Hospital | 2013-06-01 |
| NSAID Drug Interaction Study (NCT01884272) | Ardea Biosciences, Inc. | 2013-06-01 |
| A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma (NCT01897116) | Abramson Cancer Center at Penn Medicine | 2013-06-01 |
| GFM-Acadesine: A Phase I-II Trial of Acadesine (NCT01813838) | Groupe Francophone des Myelodysplasies | 2013-06-01 |
| Botulinum Toxin Injection to Prevent Ventricular Arrhythmias (NCT02003001) | Meshalkin Research Institute of Pathology of Circulation | 2013-06-01 |
| An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1) (NCT01684111) | Aktion Bronchialkarzinom e.V. | 2013-06-01 |
| A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants (NCT01871493) | Eli Lilly and Company | 2013-06-01 |
| Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma (NCT01883518) | N.N. Petrov National Medical Research Center of Oncology | 2013-06-01 |
| Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study (NCT01887743) | Children's Mercy Hospital Kansas City | 2013-06-01 |
| Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial (NCT01864824) | Harvard School of Public Health (HSPH) | 2013-06-01 |
| Impact of Oranges on Cardiovascular Health (NCT01935362) | University of Leeds | 2013-06-01 |
| Treatment of Keratoconus With PALK Versus PK (NCT02625467) | Instituto de Oftalmología Fundación Conde de Valenciana | 2013-06-01 |
| A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma (NCT01781572) | Pfizer | 2013-06-01 |
| Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine (NCT01880411) | HealthBanks Biotech Co., Ltd. | 2013-06-01 |
| UCB Therapy in Acquired Brain Injury (NCT01885663) | MinYoung Kim, M.D. | 2013-06-01 |
| Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors (NCT01858883) | Incyte Corporation | 2013-06-01 |
| Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187 (NCT01874366) | Piramal Enterprises Limited | 2013-06-01 |
| N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia (NCT01885338) | VA Greater Los Angeles Healthcare System | 2013-06-01 |
| A Study of Multiple Doses of LY2922470 in Participants With Diabetes (NCT01867216) | Eli Lilly and Company | 2013-06-01 |
| Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR (NCT01973933) | Seoul National University Hospital | 2013-06-01 |
| A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis (NCT02058524) | University of Chicago | 2013-06-01 |
| Inactivation of Whole Blood With Mirasol (NCT01907906) | Terumo BCTbio | 2013-06-01 |
| Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury (NCT02096913) | Jan M. Schwab, MD, PhD | 2013-06-01 |
| Mechanism of Action Trial of ColoAd1 (NCT02053220) | Akamis Bio | 2013-06-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects (NCT01883544) | Alexion Pharmaceuticals, Inc. | 2013-06-01 |
| Biological Half Life of DLBS1033 in Healthy Volunteers (NCT01905878) | Indonesia University | 2013-06-01 |
| A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition (NCT02498288) | GlaxoSmithKline | 2013-05-31 |
| Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT01716416) | Washington University School of Medicine | 2013-05-31 |
| Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (NCT01906164) | Alios Biopharma Inc. | 2013-05-31 |
| Preventing Stem Cell Transplant Complications With a Blood Separator Machine (NCT01866839) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-05-29 |
| Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted (NCT03649750) | Reckitt Benckiser LLC | 2013-05-29 |
| A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma) (NCT01942083) | Korea Otsuka Pharmaceutical Co., Ltd. | 2013-05-29 |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults (NCT01884922) | Gustave Roussy, Cancer Campus, Grand Paris | 2013-05-29 |
| Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma (NCT01747876) | Novartis Pharmaceuticals | 2013-05-28 |
| Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (NCT01827657) | GlaxoSmithKline | 2013-05-28 |
| Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma (NCT01866293) | Memorial Sloan Kettering Cancer Center | 2013-05-28 |
| Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects (NCT01827631) | GlaxoSmithKline | 2013-05-27 |
| Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure (NCT02057900) | Assistance Publique - Hôpitaux de Paris | 2013-05-27 |
| Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers (NCT01859117) | Celularity Incorporated | 2013-05-23 |
| Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions (NCT01797926) | GlaxoSmithKline | 2013-05-23 |
| Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease (NCT01578473) | Men's Health Boston | 2013-05-23 |
| Phase 1 Study of URC102 in Healthy Subjects (NCT01953497) | JW Pharmaceutical | 2013-05-23 |
| A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects (NCT01677741) | Novartis Pharmaceuticals | 2013-05-23 |
| An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy (NCT01887938) | Shire | 2013-05-23 |
| Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease (NCT01840956) | Humacyte, Inc. | 2013-05-23 |
| Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia (NCT01865617) | Fred Hutchinson Cancer Center | 2013-05-22 |
| Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals (NCT01862029) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-05-22 |
| Radiation and Androgen Ablation for Prostate Cancer (NCT01517451) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-05-22 |
| A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML (NCT01861002) | Therapeutic Advances in Childhood Leukemia Consortium | 2013-05-22 |
| Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma (NCT01608594) | Diwakar Davar | 2013-05-21 |
| Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study. (NCT01899638) | GlaxoSmithKline | 2013-05-20 |
| Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma (NCT01473628) | M.D. Anderson Cancer Center | 2013-05-20 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions (NCT01847417) | GlaxoSmithKline | 2013-05-16 |
| Feasibility Study of Exenatide by Continuous Subcutaneous Infusion (NCT01857895) | GlaxoSmithKline | 2013-05-16 |
| Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant (NCT01822509) | National Cancer Institute (NCI) | 2013-05-16 |
| Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome (NCT01883076) | Timothy J Nelson, MD, PhD | 2013-05-15 |
| Brain Ketone Metabolism in Type 1 Diabetes (NCT02471040) | Yale University | 2013-05-14 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions (NCT01847404) | GlaxoSmithKline | 2013-05-14 |
| Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). (NCT01852565) | GlaxoSmithKline | 2013-05-14 |
| Study of Erenumab (AMG 334) in Women With Hot Flashes (NCT01890109) | Amgen | 2013-05-13 |
| PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients (NCT01856595) | Pfizer | 2013-05-13 |
| A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis (NCT01777243) | GlaxoSmithKline | 2013-05-13 |
| A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) (NCT02055547) | Merck Sharp & Dohme LLC | 2013-05-10 |
| Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer (NCT01781403) | Asan Medical Center | 2013-05-10 |
| Therapeutic Vaccine for HIV (NCT01859325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-05-10 |
| PF-04634817 Renal Impairment Study (NCT01791855) | Pfizer | 2013-05-10 |
| A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants (NCT01866007) | Janssen Research & Development, LLC | 2013-05-09 |
| Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease (NCT01851460) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-05-08 |
| A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF (NCT01787552) | Novartis Pharmaceuticals | 2013-05-08 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) (NCT01848834) | Merck Sharp & Dohme LLC | 2013-05-07 |
| Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM (NCT02085304) | St. Joseph's Hospital and Medical Center, Phoenix | 2013-05-07 |
| Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging (NCT02311556) | Washington University School of Medicine | 2013-05-07 |
| Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies (NCT01677559) | Washington University School of Medicine | 2013-05-07 |
| A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT01763788) | Eli Lilly and Company | 2013-05-07 |
| VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors (NCT01784861) | Washington University School of Medicine | 2013-05-03 |
| NK Cells in Cord Blood Transplantation (NCT01619761) | M.D. Anderson Cancer Center | 2013-05-03 |
| A Study of LY3002813 in Participants With Alzheimer's Disease (NCT01837641) | Eli Lilly and Company | 2013-05-03 |
| Tremelimumab With Chemoembolization or Ablation for Liver Cancer (NCT01853618) | National Cancer Institute (NCI) | 2013-05-02 |
| An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects (NCT01848340) | ViiV Healthcare | 2013-05-01 |
| Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors (NCT01858155) | C17 Council | 2013-05-01 |
| An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin (NCT01816659) | M.D. Anderson Cancer Center | 2013-05-01 |
| A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers (NCT01897844) | Italfarmaco | 2013-05-01 |
| Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease (NCT01989195) | Stanford University | 2013-05-01 |
| Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007) (NCT01907724) | Merck Sharp & Dohme LLC | 2013-05-01 |
| Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) (NCT02086227) | Fresenius Kabi USA, LLC | 2013-05-01 |